| Financial Year |
March 31 2023 |
| Monetary Funds |
614,696,885.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
28,450,108.23 |
| Advances to Suppliers |
52,738.67 |
| Other Receivables |
6,887,460.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
732,402,312.47 |
| Total Current Assets |
1,382,489,505.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,971,993.30 |
| Investment Properties |
33,145,900.00 |
| Fixed Assetes |
97,440,719.31 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,146,045.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,483,093.72 |
| Deferred Income Tax Assets |
21,995,516.49 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
236,641,940.14 |
| Total Assets |
1,619,131,445.77 |
| Short-Term Loans |
132,182,810.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
355,097.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,504,807.22 |
| Taxes Payable |
5,193,975.12 |
| Interest Payable |
-- |
| Dividend Payable |
232,213.60 |
| Other payables |
60,924,941.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,345,428.49 |
| Other Current Liabilities |
15,337,692.13 |
| Sub-Total of Current Liabilities |
233,275,913.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
22,983,214.03 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,079,173.20 |
| Total Liabilities |
257,355,087.18 |
| Paid-In Capital(Or Share Stock) |
190,824,714.00 |
| Capital Surplus |
259,278,611.63 |
| Surplus Reserve |
95,412,357.00 |
| LESS:Treasury Stock |
15,003,386.69 |
| Undistributed Profits |
778,806,014.14 |
| Minority Stockholder's Interest |
40,713,290.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,321,063,068.40 |
| Owner's Equity（Stockholder's Equity） |
1,361,776,358.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,619,131,445.77 |
